Susquehanna International Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.95B | Sell |
3,210,800
-1,167,200
| -27% | -$1.18B | 0.33% | 46 |
|
|
2025
Q4 | $4.7B | Sell |
4,378,000
-489,900
| -10% | -$468M | 0.54% | 29 |
|
|
2025
Q3 | $3.71B | Buy |
4,867,900
+1,475,900
| +44% | +$1.1B | 0.42% | 42 |
|
|
2025
Q2 | $2.64B | Buy |
3,392,000
+854,200
| +34% | +$664M | 0.37% | 41 |
|
|
2025
Q1 | $2.1B | Buy |
2,537,800
+171,600
| +7% | +$143M | 0.36% | 43 |
|
|
2024
Q4 | $1.83B | Buy |
2,366,200
+203,000
| +9% | +$168M | 0.28% | 52 |
|
|
2024
Q3 | $1.92B | Buy |
2,163,200
+99,100
| +5% | +$89.1M | 0.33% | 40 |
|
|
2024
Q2 | $1.87B | Sell |
2,064,100
-217,000
| -10% | -$174M | 0.35% | 43 |
|
|
2024
Q1 | $1.77B | Buy |
2,281,100
+414,200
| +22% | +$295M | 0.31% | 49 |
|
|
2023
Q4 | $1.09B | Sell |
1,866,900
-42,700
| -2% | -$24.9M | 0.21% | 65 |
|
|
2023
Q3 | $1.03B | Buy |
1,909,600
+343,900
| +22% | +$177M | 0.21% | 57 |
|
|
2023
Q2 | $734M | Sell |
1,565,700
-634,600
| -29% | -$266M | 0.15% | 83 |
|
|
2023
Q1 | $756M | Buy |
2,200,300
+64,400
| +3% | +$21.7M | 0.16% | 84 |
|
|
2022
Q4 | $781M | Buy |
2,135,900
+59,500
| +3% | +$21.1M | 0.2% | 76 |
|
|
2022
Q3 | $671M | Buy |
2,076,400
+783,800
| +61% | +$248M | 0.17% | 69 |
|
|
2022
Q2 | $419M | Sell |
1,292,600
-8,400
| -0.6% | -$2.52M | 0.1% | 142 |
|
|
2022
Q1 | $373M | Sell |
1,301,000
-134,700
| -9% | -$34.7M | 0.06% | 221 |
|
|
2021
Q4 | $397M | Buy |
1,435,700
+210,300
| +17% | +$53.3M | 0.06% | 266 |
|
|
2021
Q3 | $283M | Sell |
1,225,400
-759,400
| -38% | -$187M | 0.04% | 394 |
|
|
2021
Q2 | $456M | Buy |
1,984,800
+706,500
| +55% | +$142M | 0.06% | 245 |
|
|
2021
Q1 | $239M | Buy |
1,278,300
+150,900
| +13% | +$29.5M | 0.04% | 390 |
|
|
2020
Q4 | $190M | Buy |
1,127,400
+113,600
| +11% | +$17M | 0.03% | 434 |
|
|
2020
Q3 | $150M | Sell |
1,013,800
-119,900
| -11% | -$18.6M | 0.03% | 424 |
|
|
2020
Q2 | $186M | Buy |
1,133,700
+26,900
| +2% | +$4.13M | 0.04% | 317 |
|
|
2020
Q1 | $154M | Buy |
1,106,800
+135,500
| +14% | +$18.6M | 0.05% | 276 |
|
|
2019
Q4 | $128M | Buy |
971,300
+138,300
| +17% | +$16M | 0.04% | 398 |
|
|
2019
Q3 | $93.2M | Sell |
833,000
-282,800
| -25% | -$31.5M | 0.03% | 462 |
|
|
2019
Q2 | $124M | Sell |
1,115,800
-1,444,400
| -56% | -$170M | 0.04% | 349 |
|
|
2019
Q1 | $332M | Buy |
2,560,200
+858,200
| +50% | +$104M | 0.14% | 115 |
|
|
2018
Q4 | $197M | Sell |
1,702,000
-68,700
| -4% | -$7.67M | 0.08% | 217 |
|
|
2018
Q3 | $190M | Buy |
1,770,700
+824,800
| +87% | +$82.5M | 0.06% | 266 |
|
|
2018
Q2 | $80.7M | Sell |
945,900
-100,700
| -10% | -$8.27M | 0.03% | 477 |
|
|
2018
Q1 | $81M | Sell |
1,046,600
-2,326,300
| -69% | -$187M | 0.03% | 462 |
|
|
2017
Q4 | $285M | Buy |
3,372,900
+1,799,300
| +114% | +$153M | 0.1% | 168 |
|
|
2017
Q3 | $135M | Sell |
1,573,600
-280,900
| -15% | -$23M | 0.05% | 296 |
|
|
2017
Q2 | $153M | Sell |
1,854,500
-704,200
| -28% | -$57.5M | 0.07% | 240 |
|
|
2017
Q1 | $215M | Sell |
2,558,700
-718,000
| -22% | -$57.5M | 0.11% | 159 |
|
|
2016
Q4 | $241M | Buy |
3,276,700
+869,600
| +36% | +$64.8M | 0.12% | 138 |
|
|
2016
Q3 | $193M | Buy |
2,407,100
+292,200
| +14% | +$23.4M | 0.09% | 169 |
|
|
2016
Q2 | $167M | Buy |
2,114,900
+415,000
| +24% | +$31.2M | 0.09% | 194 |
|
|
2016
Q1 | $122M | Sell |
1,699,900
-230,700
| -12% | -$17.5M | 0.07% | 257 |
|
|
2015
Q4 | $163M | Sell |
1,930,600
-458,800
| -19% | -$38.1M | 0.08% | 220 |
|
|
2015
Q3 | $200M | Sell |
2,389,400
-58,900
| -2% | -$4.97M | 0.09% | 199 |
|
|
2015
Q2 | $204M | Buy |
2,448,300
+516,000
| +27% | +$39.3M | 0.09% | 191 |
|
|
2015
Q1 | $140M | Sell |
1,932,300
-128,000
| -6% | -$9.11M | 0.06% | 271 |
|
|
2014
Q4 | $142M | Buy |
2,060,300
+549,600
| +36% | +$37.1M | 0.06% | 303 |
|
|
2014
Q3 | $98M | Sell |
1,510,700
-307,700
| -17% | -$19.5M | 0.04% | 416 |
|
|
2014
Q2 | $113M | Sell |
1,818,400
-776,700
| -30% | -$46.3M | 0.05% | 332 |
|
|
2014
Q1 | $153M | Buy |
2,595,100
+817,700
| +46% | +$45.6M | 0.07% | 237 |
|
|
2013
Q4 | $90.6M | Sell |
1,777,400
-214,600
| -11% | -$10.7M | 0.04% | 386 |
|
|
2013
Q3 | $100M | Buy |
1,992,000
+397,600
| +25% | +$20.8M | 0.05% | 309 |
|
|
2013
Q2 | $78.3M | Buy |
+1,594,400
| New | +$86.8M | 0.04% | 354 |
|
Other funds holding LLY
VCM
VPM
Susquehanna International Group's LLY Position: Q1 2026 in Review
Susquehanna International Group reduced its Eli Lilly (LLY) stake by 35% in Q1 2026, selling an estimated $42.1M and leaving 78,552 shares worth $72.2M. The position accounts for 0.01% of the portfolio, ranked #1025.
Susquehanna International Group first reported a position in LLY in Q2 2013 and has held it in 48 quarters since. The position peaked at $383M in Q3 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Susquehanna International Group held 78,552 shares of Eli Lilly worth $72.2M as of Q1 2026.
- Susquehanna International Group sold 41,523 Eli Lilly shares in Q1 2026, an estimated $42.1M.
- Eli Lilly made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1025 holding.
- Susquehanna International Group first reported a position in Eli Lilly in Q2 2013 and has held it in 48 quarters since.
- Susquehanna International Group's Eli Lilly position peaked at $383M in Q3 2024.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.